Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Clostridium tetani toxin antigen, commonly known as tetanus toxin or TeNT, is a potent neurotoxin produced by the bacterium Clostridium tetani. This protein is responsible for the clinical manifestations of tetanus, a severe neurological disease characterized by spastic paralysis. It acts as a zinc-dependent endopeptidase that specifically cleaves synaptobrevin (VAMP2), a vesicle-associated membrane protein critical for neurotransmitter release. Vaccination with chemically inactivated toxoid induces robust protective immunity against tetanus.
Zinc-dependent endopeptidase that cleaves synaptobrevin (VAMP2) leading to inhibition of neurotransmitter release in inhibitory interneurons.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridium tetani toxin antigen (TeNT).